GOH KHOON SENG, GLOBAL MARKETING DIRECTOR OSTEOPORE
Over his 30-year career in the medical device industry, Mr Goh has always been passionate about improving patients’ lives by developing and bringing technological advancements to medical practitioners. His experience spans both start-ups and global multinational corporations, with over 20 years in mid and senior management with Medtronic plc (the world's largest medical device company) and Edwards Lifesciences before joining Osteopore as a director in 2015.
- Osteopore (OSX:ASX), Partnership
Osteopore stands as a regenerative medtech powerhouse, says RSM Report on Australia Medtech Sector
Osteopore International's regenerative medicine journey is now showcased in the latest RSM Australia industry report 'The future of MedTech in Australia'.
1 minute read
- Osteopore (OSX:ASX), Tech, Press Release (OSX.AX)
Osteopore enters into Orthopaedic research collaboration
Osteopore Limited (ASX:OSX), a revenue-generating manufacturer of regenerative implants that...
1 minute read
- Osteopore (OSX:ASX), Press Release (OSX.AX), Tech
Osteopore bolsters Scientific & Clinical Advisory Panel
Osteopore Limited (ASX: OSX), a global leader in the manufacture of innovative regenerative implants that empower natural tissue regeneration, is pleased to introduce that Dr Rondhir Jithoo, Associate Professor Lim Thiam Chye, and Associate Professor Yeo Tseng Tsai, have joined our Scientific and Clinical Advisory Panel (SCAP).
2 minute read
- Osteopore (OSX:ASX), Tech
What are bioresorbable implants and why Osteopore is committed to them
At Osteopore, we are global leaders in the design and manufacture of regenerative biomimetic...
1 minute read
- Tech
3D Printing Enables Microarchitecture Required in Biomimetic Scaffolds
The science of tissue engineering and regenerative medicine aims to provide surgeons with a...
1 minute read
- Tech
Regrowing Damaged Body Parts: How One Australian-listed Company is Making it Accessible
Osteopore, an Australian and Singapore based...
1 minute read
- Osteopore (OSX:ASX), Partnership, Asia
The Suzhou Industrial Park and Collaboration
At Osteopore, one of our guiding principles is the value of collaboration. We believe that it is...
-3 minute read
- Tech
In-vitro vs in-situ tissue engineering. What are the differences?
There is a lot of hype around in-vitro tissue engineering, because ‘growing an organ in a lab’...
2 minute read
Top Posts
- In-vitro vs in-situ tissue engineering. What are the differences?
- Regrowing Damaged Body Parts: How One Australian-listed Company is Making it Accessible
- The Suzhou Industrial Park and Collaboration
- Bringing 3D printing to the next level for sustainable healing
- What are bioresorbable implants and why Osteopore is committed to them